Orphan drugs are specific pharmaceutical agents
which are developed for treatment of orphan or rare diseases. Orphan disease,
according to laws of various countries, may include medical conditions which
have low prevalence, i.e. affects less than 200,000 persons (U.S.), or 50,000
(Japan). Expiring patents of blockbuster drugs, drying pipelines, stringent
regulations across the globe, has encouraged the pharmaceutical industries to
shift the focus to a new business model that includes niche busters or orphan
drugs.
Currently, around 7,000 diseases are recognized as orphan
and around 250 new diseases are added to the list every year. Orphan drug laws
introduced and implemented in countries such as the U.S., Japan, Singapore,
Australia, and the European Union, have stimulated the orphan drug market and
shifted the focus of pharmaceutical companies towards incentives on developing
orphan drugs. The orphan drugs market currently forms around six percent of the
total pharmaceutical market. However, this market is expected to register
double digit growth to outshine the mainstream drugs market in the near future.
Orphan drugs market
will be driven by the R&D benefits or grants availed, FDA fee waiver
benefits, and shorter development timelines along with favorable reimbursement,
prolonged exclusivity, premium pricing and fewer hurdles for getting approval
of the drug. However, the market confronts the challenge of locating or
recruiting patient for trials. Nevertheless, the orphan drug market is expected
to maintain a competitive edge over the traditional drug model.
Some of the major
players in the orphan drug market include Pfizer, Genentech, Abbott
Laboratories, Amgen, Inc., Sanofi Aventis, Janssen Biotech, Inc. among others.
More Report on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This
report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons
for Buying this Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological growth
map over time to understand the industry growth rate
- It provides a seven-year forecast
assessed on the basis of how the market is predicted to grow
·
It helps in making informed business
decisions by having complete insights of market and by making in-depth analysis
of market segments.
Download PDF: Orphan Drugs Market
About Us:-
Transparency Market
Research (TMR) is a market intelligence company providing global business
research reports and consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights for thousands
of decision-makers.
TMR’s
experienced team of analysts, researchers, and consultants use proprietary data
sources along with various tools and techniques to gather and analyze
information. Our business offerings represent the latest and the most reliable
information which is indispensable for businesses to sustain their competitive
edge.
Contact
Us:
Sheela
AK
State
Tower,
90
State Street,
Suite
700,
Albany
NY – 12207
United
States
Tel:
+1-518-618-1030
Browse Market Researche Report:-
0 comments:
Post a Comment